BIBLIOGRAPHIC RECORD

Mutant KRAS is a druggable target for pancreatic cancer

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Elina Zorde Khvalevsky; Rachel Malka Gabai; Itzhak H. Rachmut; E. Philip Horwitz; Zivia Brunschwig; Ariel Orbach; Adva Shemi; Talia Golan; Abraham Jacob Domb; Eylon Yavin; Hilla Giladi; Ludmila Rivkin; Alina Simerzin; Rami Eliakim; Abed Khalaileh; Ayala Hubert; Maor Lahav; Yael Kopelman; Eran Goldin; Alan Dancour; Yael Hants; Sagit Arbel-Alon; Rinat Abramovitch; Amotz Shemi; Eithan Galun
Source of metadata
OpenAlex
Year recorded
2013

Public identifiers and source

Open the source record

Reference

Elina Zorde Khvalevsky; Rachel Malka Gabai; Itzhak H. Rachmut; E. Philip Horwitz; Zivia Brunschwig; Ariel Orbach; Adva Shemi; Talia Golan; Abraham Jacob Domb; Eylon Yavin; Hilla Giladi; Ludmila Rivkin; Alina Simerzin; Rami Eliakim; Abed Khalaileh; Ayala Hubert; Maor Lahav; Yael Kopelman; Eran Goldin; Alan Dancour; Yael Hants; Sagit Arbel-Alon; Rinat Abramovitch; Amotz Shemi; Eithan Galun. (2013). Mutant KRAS is a druggable target for pancreatic cancer. https://openalex.org/W2135500767

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-5b1cb6776eb5adec499df8e831a912a1/